Teva reported a 3% revenue growth in its Europe segment as of July 30, 2025.
2 reports, 2 independent
Updated Jul 30
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Teva reported a 3% revenue growth in its Europe segment as of July 30, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Europe
terrestrial continent located in north-western Eurasia
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Related events
- Sales grew 5% in the European segment for Thor Industries.
- Interface, Inc. reported its revenue breakdown for August 2026, noting that 29% of its revenue came from Europe, while 60% came from the Americas.
- Markets in Europe and North America are contributing to the overall revenue growth and company performance.
- An institute forecasts European economic growth at 1.4 percent, noting Germany as the largest economy.
- Persistent Systems reported a revenue mix shift to 22% from Europe and completed the acquisition of Nagarro SE for €1.27 billion.
Coverage
Newest first; wire copies grouped- GlobeNewswireTeva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components On track for 30
- Business WireHayward Holdings Reports Second Quarter Fiscal Year 2025 Financial Results and Refines 2025 Guidance SECOND QUARTER FISCAL 2025 SUMMARY Net Sales increased 5% year-over-year to $299.6 million Net Inc